Phosphorylated S6 Ribosomal Protein: A Novel Biomarker of Antibody‐Mediated Rejection in Heart Allografts

We tested the hypothesis that phosphorylation of S6 ribosomal protein (S6RP), a downstream target of the PI3K/Akt/mTOR pathway, is a biomarker of antibody‐mediated rejection (AMR) in heart allografts. Primary cultures of human aortic and microvascular endothelial cells (EC) were treated with anti‐HL...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of transplantation Vol. 6; no. 7; pp. 1560 - 1571
Main Authors:	Lepin, E. J., Zhang, Q., Zhang, X., Jindra, P. T., Hong, L. S., Ayele, P., Peralta, M. V. P., Gjertson, D. W., Kobashigawa, J. A., Wallace, W. D., Fishbein, M. C., Reed, E. F.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Publishing Ltd 01-07-2006
Subjects:	Acute Disease Alloantibodies Antibodies - immunology Biomarkers Biopsy Cells, Cultured endothelial cells Endothelial Cells - immunology Endothelial Cells - metabolism Graft Rejection - enzymology Graft Rejection - immunology Heart Transplantation - immunology heart/lung transplantation histocompatibility antigens Histocompatibility Antigens Class I - immunology Histocompatibility Antigens Class II - immunology Humans Myocardium - metabolism Phosphorylation Protein Kinases - metabolism rejection Ribosomal Protein S6 - metabolism Signal Transduction Transplantation, Homologous - immunology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	We tested the hypothesis that phosphorylation of S6 ribosomal protein (S6RP), a downstream target of the PI3K/Akt/mTOR pathway, is a biomarker of antibody‐mediated rejection (AMR) in heart allografts. Primary cultures of human aortic and microvascular endothelial cells (EC) were treated with anti‐HLA class I and class II antibodies (Ab) and cell lysates were studied for phosphorylation of S6 ribosmal protein at Serine235/236 (p‐S6RP). Treatment of cultured EC with anti‐class I and class II Ab stimulated S6RP phosphorylation. Immunohistochemical techniques were used to detect the level of p‐S6RP in endomyocardial biopsies (n = 131) from 46 heart transplant recipients and the results were correlated with histopathological diagnosis of rejection, C4d staining, production of posttransplant anti‐HLA Ab and clinical outcome. Increased phosphorylation of S6RP in endomyocardial biopsies was significantly associated with the diagnosis of AMR (p < 0.0001). No significant association between acute cellular rejection (ACR) and p‐S6RP was observed. C4d staining was positively associated with both AMR and p‐S6RP. Posttransplant anti‐HLA class II Ab production was also significantly associated with a positive p‐S6RP status in cardiac biopsies. These results indicate that p‐S6RP is a useful biomarker for the diagnosis of AMR. Human anti‐HLA antibodies stimulate phosphorylation of S6 ribosomal protein in cultured endothelial cells, and increased phosphorylation of this protein is also seen in endomyocardial biopsies of heart transplants with antibody‐mediated rejection.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1600-6135 1600-6143
DOI:	10.1111/j.1600-6143.2006.01355.x